ARDX- Ardelyx, Inc.

Name: Ardelyx, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ardelyx, Inc. (ARDX) has 15 insiders with recent SEC Form 4 filings, including 1 buy and 13 sells. ARDX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Mott David M	3.30M	$23.62M	-
CEO	Raab Michael	1.46M	$10.41M	-
Other	Williams Laura A	409.9K	$2.93M	-
CFO	Renz Justin A	409.1K	$2.92M	-
Other	Bishop John E	339.2K	$2.42M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 20, 2026	Reilly Joseph James	See Remarks	Sell	4,991	$5.85	$29,180.86	-1.1%	-	-
Feb 20, 2026	Bishop John E	See Remarks	Sell	3,179	$5.85	$18,586.31	-0.3%	-	-
Feb 20, 2026	Mott David M88	Director	Buy	333,333	$5.84	$1,946,331.39	+11.2%	-	-
Jan 8, 2026	Williams Laura A56	Chief Patient Officer	Sale+OE	50,000	$6.98	$348,900.00	-12.1%	-12.9%	-
Nov 21, 2025	Kelliher Mike	See Remarks	Sell	5,560	$5.54	$30,785.16	-2.0%	+24.4%	-
Nov 21, 2025	Williams Laura A56	Chief Patient Officer	Sell	6,426	$5.54	$35,580.12	-1.8%	+24.4%	-
Nov 21, 2025	Foster Eric Duane	Chief Commercial Officer	Sell	5,814	$5.54	$32,191.54	-1.9%	+24.4%	-
Nov 21, 2025	Grammer Elizabeth A58	See Remarks	Sell	5,995	$5.54	$33,193.72	-2.0%	+24.4%	-
Nov 21, 2025	Raab Michael57	President &CEO	Sell	46,887	$5.54	$259,608.63	-3.1%	+24.4%	-
Nov 21, 2025	Reilly Joseph James	See Remarks	Sell	11,086	$5.54	$61,382.07	-9.2%	+24.4%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC